Berlin, Germany — January 2026 — StratifAI, the precision oncology company advancing cancer diagnostics through AI-driven biomarkers, has achieved ISO 27001 and ISO 27701 certifications, successfully completed a SOC 2 Type II audit and maintains full GDPR and HIPAA compliance for its multimodal biomarker discovery platform, Polaris™.
These certifications underline that Polaris™ meets internationally recognized requirements for information security management, privacy protection, and operational controls, providing a robust foundation for the responsible use of AI in healthcare.
Enabling secure adoption of AI in healthcare
As AI technologies are increasingly adopted across research and clinical development workflows, expectations around security, governance, and technical robustness continue to rise. StratifAI is holding Polaris™ to the highest internationally recognized standards for data security and privacy to support responsible implementation of AI in healthcare environments.
With independently audited controls in place, Polaris™ enables technically safe and well-governed use of AI in workflows involving sensitive clinical data, supporting biomarker discovery and research within established regulatory and institutional frameworks.
A foundation for global collaboration
This foundation enables StratifAI to scale its partnerships internationally. Hospitals, academic centers, and life sciences organizations can engage with Polaris™ platform with consistent safeguards across data access, processing, and use. As StratifAI continues to expand, these milestones support broader collaboration and long-term adoption of Polaris™.
